Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.

@article{Schultz2014HealthCA,
  title={Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.},
  author={Kris Ann P Schultz and Lu Chen and Zhengjia Chen and Toana I Kawashima and Kevin Charles Oeffinger and William G A Woods and H. Stacy Nicholson and Joseph Philip Neglia},
  journal={Pediatric blood & cancer},
  year={2014},
  volume={61 4},
  pages={729-36}
}
BACKGROUND Therapy for childhood acute myeloid leukemia (AML) has historically included chemotherapy with or without autologous bone marrow transplant (autoBMT) or allogeneic hematopoietic stem cell transplantation (alloBMT). We sought to compare health-related quality-of-life (HRQOL) outcomes between these treatment groups. PROCEDURE Five-year survivors of AML diagnosed before age 21 and enrolled and treated from 1979 to 1995 on one of 4 national protocols were interviewed. These survivors… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009
View 1 Excerpt

Quality of life among long-term adolescent and adult survivors of childhood cancer

E Maunsell, L Pogany, BarreraM
J Clin Oncol 2006;24:2527–2535 • 2006
View 1 Excerpt

Similar Papers

Loading similar papers…